Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE43.8500
- TODAY'S CHANGE (%)0.1200 (0.2744%)
- Bid / Lots35.0000/ 1
- Ask / Lots46.2700/ 1
- Open / Previous Close43.9800 / 43.7300
- Day Range
- 52 Week Range
- Volume424,596
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 1191 | 43.98 |
| 09:38 ET | 200 | 44.12 |
| 09:39 ET | 100 | 43.78 |
| 09:41 ET | 400 | 43.825 |
| 09:43 ET | 3757 | 44.055 |
| 09:45 ET | 300 | 43.88 |
| 09:48 ET | 704 | 43.96 |
| 09:50 ET | 2489 | 43.94 |
| 09:52 ET | 100 | 44.05 |
| 09:54 ET | 4369 | 44.34 |
| 09:56 ET | 100 | 44.345 |
| 09:57 ET | 2806 | 44.03 |
| 09:59 ET | 400 | 44.18 |
| 10:01 ET | 104 | 44.04 |
| 10:06 ET | 1336 | 44.11 |
| 10:10 ET | 100 | 44.035 |
| 10:15 ET | 422 | 44.125 |
| 10:17 ET | 100 | 44.07 |
| 10:19 ET | 200 | 44.12 |
| 10:21 ET | 1050 | 44.1 |
| 10:28 ET | 1328 | 43.8101 |
| 10:30 ET | 300 | 43.8 |
| 10:32 ET | 5759 | 43.895 |
| 10:33 ET | 3571 | 43.935 |
| 10:35 ET | 398 | 43.78 |
| 10:39 ET | 200 | 43.6 |
| 10:42 ET | 308 | 43.6272 |
| 10:44 ET | 400 | 43.635 |
| 10:48 ET | 200 | 43.61 |
| 10:55 ET | 100 | 43.59 |
| 11:00 ET | 320 | 43.7 |
| 11:02 ET | 100 | 43.7 |
| 11:06 ET | 300 | 43.79 |
| 11:11 ET | 100 | 43.83 |
| 11:13 ET | 100 | 43.91 |
| 11:18 ET | 2044 | 43.695 |
| 11:22 ET | 100 | 43.61 |
| 11:24 ET | 600 | 43.72 |
| 11:27 ET | 321 | 43.59 |
| 11:33 ET | 400 | 43.61 |
| 11:36 ET | 232 | 43.65 |
| 11:42 ET | 300 | 43.51 |
| 11:49 ET | 200 | 43.65 |
| 11:54 ET | 200 | 43.57 |
| 11:56 ET | 400 | 43.535 |
| 11:58 ET | 700 | 43.54 |
| 12:02 ET | 100 | 43.54 |
| 12:03 ET | 3200 | 43.55 |
| 12:05 ET | 650 | 43.51 |
| 12:09 ET | 300 | 43.575 |
| 12:12 ET | 708 | 43.555 |
| 12:14 ET | 200 | 43.4807 |
| 12:16 ET | 100 | 43.58 |
| 12:18 ET | 200 | 43.575 |
| 12:20 ET | 100 | 43.58 |
| 12:21 ET | 576 | 43.535 |
| 12:25 ET | 800 | 43.63 |
| 12:27 ET | 1252 | 43.675 |
| 12:36 ET | 200 | 43.65 |
| 12:43 ET | 300 | 43.67 |
| 12:45 ET | 100 | 43.68 |
| 12:48 ET | 4483 | 43.79 |
| 12:50 ET | 800 | 43.825 |
| 12:59 ET | 371 | 43.77 |
| 01:03 ET | 300 | 43.84 |
| 01:08 ET | 100 | 43.83 |
| 01:12 ET | 800 | 43.79 |
| 01:14 ET | 200 | 43.79 |
| 01:15 ET | 2605 | 43.825 |
| 01:17 ET | 100 | 43.82 |
| 01:19 ET | 4705 | 43.93 |
| 01:21 ET | 300 | 43.95 |
| 01:24 ET | 2150 | 43.95 |
| 01:26 ET | 200 | 43.95 |
| 01:28 ET | 2360 | 43.94 |
| 01:35 ET | 900 | 43.97 |
| 01:37 ET | 100 | 43.99 |
| 01:39 ET | 200 | 44.015 |
| 01:42 ET | 900 | 44.06 |
| 01:44 ET | 800 | 44 |
| 01:46 ET | 427 | 43.9 |
| 01:48 ET | 1900 | 43.935 |
| 01:50 ET | 1100 | 43.925 |
| 01:51 ET | 3243 | 43.97 |
| 01:53 ET | 625 | 43.945 |
| 01:55 ET | 500 | 43.99 |
| 02:00 ET | 300 | 43.99 |
| 02:02 ET | 800 | 43.99 |
| 02:04 ET | 600 | 44.01 |
| 02:06 ET | 408 | 44.04 |
| 02:09 ET | 200 | 44.02 |
| 02:11 ET | 33270 | 43.945 |
| 02:13 ET | 9473 | 43.895 |
| 02:15 ET | 500 | 43.88 |
| 02:18 ET | 600 | 43.895 |
| 02:20 ET | 200 | 43.885 |
| 02:22 ET | 1579 | 43.885 |
| 02:24 ET | 4068 | 43.99 |
| 02:26 ET | 700 | 43.93 |
| 02:27 ET | 599 | 43.955 |
| 02:29 ET | 320 | 43.91 |
| 02:31 ET | 100 | 43.95 |
| 02:33 ET | 760 | 43.98 |
| 02:36 ET | 200 | 43.98 |
| 02:38 ET | 140 | 43.98 |
| 02:42 ET | 100 | 44 |
| 02:44 ET | 2100 | 43.945 |
| 02:45 ET | 3766 | 43.945 |
| 02:47 ET | 3152 | 43.895 |
| 02:49 ET | 4605 | 43.895 |
| 02:51 ET | 1000 | 43.92 |
| 02:54 ET | 604 | 43.97 |
| 02:56 ET | 1400 | 43.95 |
| 02:58 ET | 3306 | 43.94 |
| 03:00 ET | 600 | 43.945 |
| 03:02 ET | 3528 | 43.88 |
| 03:03 ET | 916 | 43.83 |
| 03:05 ET | 516 | 43.835 |
| 03:07 ET | 1300 | 43.835 |
| 03:14 ET | 3390 | 43.965 |
| 03:16 ET | 7533 | 43.95 |
| 03:18 ET | 505 | 43.95 |
| 03:20 ET | 100 | 43.95 |
| 03:23 ET | 442 | 43.95 |
| 03:25 ET | 400 | 43.95 |
| 03:27 ET | 900 | 43.99 |
| 03:30 ET | 1397 | 43.965 |
| 03:32 ET | 347 | 43.965 |
| 03:34 ET | 4305 | 43.93 |
| 03:36 ET | 6414 | 43.925 |
| 03:38 ET | 1200 | 43.93 |
| 03:39 ET | 929 | 43.93 |
| 03:41 ET | 1000 | 43.965 |
| 03:43 ET | 2210 | 43.92 |
| 03:45 ET | 2245 | 43.94 |
| 03:48 ET | 3612 | 43.805 |
| 03:50 ET | 2536 | 43.8575 |
| 03:52 ET | 1000 | 43.865 |
| 03:54 ET | 9706 | 43.885 |
| 03:56 ET | 11331 | 43.835 |
| 03:57 ET | 11151 | 43.765 |
| 03:59 ET | 40525 | 43.85 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.3B | -16.2x | --- |
Biohaven Ltd | 3.4B | -5.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
IDEAYA Biosciences Inc | 3.5B | -21.1x | --- |
MoonLake Immunotherapeutics | 2.9B | -59.9x | --- |
Immunitybio Inc | 3.7B | -5.2x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
- Chief Medical Officer
- Christopher Kenney
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -16.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
